Clinical Decision Support Tools for Antibiotic Prescribing

NCT ID: NCT03580603

Last Updated: 2021-05-06

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 273 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-03-05
• Study Completion Date: 2018-09-30

Brief Summary

The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.

Conditions

Infectious Disease

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Antibiotic visualization tool

Provider will answer microbiological sensitivity questions using a new antibiotic visualization tool.

Group Type: EXPERIMENTAL

Visualization tool

Intervention Type: OTHER

Visual representation of past microbiological culture data

Standard practice

Provider will answer microbiological sensitivity questions using standard medical record tools.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Visualization tool

Visual representation of past microbiological culture data

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• provider is caring for a patient with a previous positive urine or blood cultures
• provider is caring for a patient currently in a clinical location being investigated
• provider is caring for a patient with orders placed for an intravenous, intramuscular, oral antibiotics

Exclusion Criteria

• the patient has already received the antibiotic by the time of the intervention
• the antibiotic has been cancelled by the time of intervention
• the research assistant is unable to reach the ordering provider before the visit is completed
• participation by the clinician in the study would impede clinical care
• age < 18

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Beth Israel Deaconess Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Steven Horng, MD

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Steven Horng, MD

Role: PRINCIPAL_INVESTIGATOR

Beth Israel Deaconess Medical Center

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Countries

United States

Other Identifiers

2017P000432

Identifier Type: OTHER

Identifier Source: secondary_id

2017P000432

Identifier Type: -

Identifier Source: org_study_id